Technology
Health
Biotechnology

AzurRx BioPharma

$1.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-2.38%) As of 12:08 PM EDT today
-$0.03 (-2.38%) Today

Why Robinhood?

You can buy or sell AZRX and other stocks, options, ETFs, and crypto commission-free!

About AZRX

AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. It focuses on MS1819-SD, and B-Lactamase program products. Read More The company was founded on January 30, 2014 and is headquartered in Brooklyn, NY.

Employees
12
Headquarters
Brooklyn, New York
Founded
2014
Market Cap
19.46M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
485.50K
High Today
$1.28
Low Today
$0.988
Open Price
$1.05
Volume
675.73K
52 Week High
$3.75
52 Week Low
$0.9052

Collections

Technology
Health
Biotechnology
2016 IPO
US
North America

AZRX Earnings

-$0.29
-$0.24
-$0.20
-$0.15
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 12, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.